OurCrowd portfolio company ReWalk, developer of the FDA approved ReWalk exoskeleton device, was featured on CNN Money. ReWalk is the developer of the FDA approved ReWalk exoskeleton device, providing paraplegics with an independent, natural walking experience that provides them numerous social, psychological, and physical benefits.
ReWalk (RWLK) is the brainchild of Israeli scientist Dr. Amit Goffer who, after an ATV accident in 1997, became a quadriplegic. Goffer grew frustrated with the limitations of wheelchairs.
“Once I realized there was not an alternative to the wheelchair, I couldn’t understand why,” said Goffer.
He says he had always been an entrepreneur and he began prototyping the ReWalk in his garage.
ReWalk raised $1,320,000 from OurCrowd investors in June 2013.
Read more on CNN Money here.
The article also contains a video segment on ReWalk, watch it below:
![[Zippin in PR Newswire] Zippin Hires Former VP of SSP and Aramark, Gary Jacobus, to Lead Business Development](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
